0000000000499261

AUTHOR

M. Kumar

showing 15 related works from this author

Search for an Invisibly Decaying Z′ Boson at Belle II in e+e−→μ+μ−(e±μ∓) Plus Missing Energy Final States

2020

Theories beyond the standard model often predict the existence of an additional neutral boson, the Z′. Using data collected by the Belle II experiment during 2018 at the SuperKEKB collider, we perform the first searches for the invisible decay of a Z′ in the process e+e-→μ+μ-Z′ and of a lepton-flavor-violating Z′ in e+e-→e±μZ′. We do not find any excess of events and set 90% credibility level upper limits on the cross sections of these processes. We translate the former, in the framework of an Lμ-Lτ theory, into upper limits on the Z′ coupling constant at the level of 5×10-2-1 for MZ′≤6 GeV/c2.

PhysicsCoupling constantParticle physicsMissing energyPhysics beyond the Standard ModelGeneral Physics and Astronomy01 natural scienceslaw.inventionlaw0103 physical sciencesHigh Energy Physics::Experiment010306 general physicsColliderBosonPhysical Review Letters
researchProduct

Search for Axionlike Particles Produced in e+e− Collisions at Belle II

2020

We present a search for the direct production of a light pseudoscalar a decaying into two photons with the Belle II detector at the SuperKEKB collider. We search for the process e+e-→γa, a→γγ in the mass range 0.2<ma<9.7 GeV/c2 using data corresponding to an integrated luminosity of (445±3) pb-1. Light pseudoscalars interacting predominantly with standard model gauge bosons (so-called axionlike particles or ALPs) are frequently postulated in extensions of the standard model. We find no evidence for ALPs and set 95% confidence level upper limits on the coupling strength gaγγ of ALPs to photons at the level of 10-3 GeV-1. The limits are the most restrictive to date for 0.2<ma<1 GeV/c2.

PhysicsRange (particle radiation)Particle physicsGauge bosonLuminosity (scattering theory)Photon010308 nuclear & particles physicsGeneral Physics and Astronomy01 natural scienceslaw.inventionStandard ModelPseudoscalarDirect productionlaw0103 physical sciencesHigh Energy Physics::Experiment010306 general physicsColliderPhysical Review Letters
researchProduct

The Belle II vertex detector integration

2019

Belle II DEPFET, PXD, and SVD Collaborations: et al.

Nuclear and High Energy PhysicsPhysics::Instrumentation and DetectorsSilicon sensorPhase (waves)Computer Science::Computational Geometry7. Clean energy01 natural scienceslaw.inventionNuclear physicsBelle II; Data acquisition; Pixel detector; Silicon sensor; Strip detector; Vertex detector; Nuclear and High Energy Physics; InstrumentationData acquisitionlaw0103 physical sciencesVertex detectorBelle IIStrip detectorColliderInstrumentationNuclear and High Energy PhysicPhysicsInterconnectionPixel010308 nuclear & particles physicsDetectorBelle II; data acquisition; pixel detector; silicon sensor; strip detector; vertex detectorData acquisitionPixel detectorUpgradeHigh Energy Physics::ExperimentFocus (optics)Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment
researchProduct

Precise Measurement of the D0 and D+ Lifetimes at Belle II

2021

We report a measurement of the D^{0} and D^{+} lifetimes using D^{0}→K^{-}π^{+} and D^{+}→K^{-}π^{+}π^{+} decays reconstructed in e^{+}e^{-}→cc[over ¯] data recorded by the Belle II experiment at the SuperKEKB asymmetric-energy e^{+}e^{-} collider. The data, collected at center-of-mass energies at or near the ϒ(4S) resonance, correspond to an integrated luminosity of 72  fb^{-1}. The results, τ(D^{0})=410.5±1.1(stat)±0.8(syst)  fs and τ(D^{+})=1030.4±4.7(stat)±3.1(syst)  fs, are the most precise to date and are consistent with previous determinations.

PhysicsParticle physics010308 nuclear & particles physicslaw0103 physical sciencesGeneral Physics and AstronomyResonance010306 general physicsCollider01 natural scienceslaw.inventionLuminosityPhysical Review Letters
researchProduct

Alignment for the first precision measurements at Belle II

2019

On March 25th 2019, the Belle II detector recorded the first collisions delivered by the SuperKEKB accelerator. This marked the beginning of the physics run with vertex detector. The vertex detector was aligned initially with cosmic ray tracks without magnetic field simultaneously with the drift chamber. The alignment method is based on Millepede II and the General Broken Lines track model and includes also the muon system or primary vertex position alignment. To control weak modes, we employ sensitive validation tools and various track samples can be used as alignment input, from straight cosmic tracks to mass-constrained decays. With increasing luminosity and experience, the alignment is …

QC1-999vertex detectorDetector calibrationBELLECosmic rayprogramming01 natural sciencesNuclear physics0103 physical sciences[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex][INFO]Computer Science [cs][PHYS.PHYS.PHYS-INS-DET]Physics [physics]/Physics [physics]/Instrumentation and Detectors [physics.ins-det]010306 general physicsPhysicsMuonCOSMIC cancer database010308 nuclear & particles physicsPhysicsDetectordetector: alignmenttracksMagnetic fieldVertex (geometry)cosmic radiationdrift chamberHigh Energy Physics::ExperimentVertex detectorperformance
researchProduct

Search for B+→K+νν¯ Decays Using an Inclusive Tagging Method at Belle II

2021

A search for the flavor-changing neutral-current decay B^{+}→K^{+}νν[over ¯] is performed at the Belle II experiment at the SuperKEKB asymmetric energy electron-positron collider. The data sample corresponds to an integrated luminosity of 63 fb^{-1} collected at the ϒ(4S) resonance and a sample of 9 fb^{-1} collected at an energy 60 MeV below the resonance. Because the measurable decay signature involves only a single charged kaon, a novel measurement approach is used that exploits not only the properties of the B^{+}→K^{+}νν[over ¯] decay, but also the inclusive properties of the other B meson in the ϒ(4S)→BB[over ¯] event, to suppress the background from other B meson decays and light-qua…

PhysicsParticle physicsLuminosity (scattering theory)010308 nuclear & particles physicsBranching fractionElectron–positron annihilationGeneral Physics and AstronomyResonance01 natural scienceslaw.inventionPair productionlaw0103 physical sciencesHigh Energy Physics::ExperimentB meson010306 general physicsColliderEnergy (signal processing)Physical Review Letters
researchProduct

Data quality monitors of vertex detectors at the start of the Belle II experiment

2019

The Belle II experiment features a substantial upgrade of the Belle detector and will operate at the SuperKEKB energy-asymmetric e+e− collider at KEK in Tsukuba, Japan. The accelerator completed its first phase of commissioning in 2016, and the Belle II detector saw its first electron-positron collisions in April 2018. Belle II features a newly designed silicon vertex detector based on double-sided strip layers and DEPFET pixel layers. A subset of the vertex detector was operated in 2018 to determine background conditions (Phase 2 operation). The collaboration completed full detector installation in January 2019, and the experiment started full data taking. This paper will report on the fin…

Physics::Instrumentation and DetectorsQC1-999vertex detectorBELLEquality: monitoring01 natural sciences7. Clean energyprogrammingSilicon vertex detectorlaw.inventionNuclear physicssemiconductor detector: pixellaw0103 physical sciencesQuality monitoring[INFO]Computer Science [cs][PHYS.PHYS.PHYS-INS-DET]Physics [physics]/Physics [physics]/Instrumentation and Detectors [physics.ins-det]010306 general physicsCollidernumerical calculationsdetector: designactivity reportPhysics010308 nuclear & particles physicsPhysicsDetectorUpgradeFull dataData qualityPhysics::Accelerator Physicssemiconductor detector: microstripHigh Energy Physics::ExperimentupgradeVertex detectormonitoring: on-lineperformance
researchProduct

The Belle II Physics Book

2019

cd. autorów: L. Cao48,‡, G. Caria145,‡, G. Casarosa57,‡, C. Cecchi56,‡,D. Cˇ ervenkov10,‡,M.-C. Chang22,‡, P. Chang92,‡, R. Cheaib146,‡, V. Chekelian83,‡, Y. Chen154,‡, B. G. Cheon28,‡, K. Chilikin77,‡, K. Cho70,‡, J. Choi14,‡, S.-K. Choi27,‡, S. Choudhury35,‡, D. Cinabro170,‡, L. M. Cremaldi146,‡, D. Cuesta47,‡, S. Cunliffe16,‡, N. Dash33,‡, E. de la Cruz Burelo9,‡, E. de Lucia52,‡, G. De Nardo54,‡, †Editor. ‡Belle II Collaborator. §Theory or external contributing author. M. De Nuccio16,‡, G. De Pietro59,‡, A. De Yta Hernandez9,‡, B. Deschamps129,‡, M. Destefanis60,‡, S. Dey116,‡, F.Di Capua54,‡, S.Di Carlo75,‡, J. Dingfelder129,‡, Z. Doležal10,‡, I. Domínguez Jiménez125,‡, T.V. Dong30,26,…

B: semileptonic decayPhysics beyond the Standard ModelHadronelectroproduction [charmonium]General Physics and AstronomyComputingMilieux_LEGALASPECTSOFCOMPUTINGB: radiative decayannihilation [electron positron]7. Clean energy01 natural sciencescharmonium: electroproductionB physicsHigh Energy Physics - Experimentlaw.inventionHigh Energy Physics - Experiment (hep-ex)High Energy Physics - Phenomenology (hep-ph)Z'law[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Charm (quantum number)dark sector searchesPhysicslifetimeradiative decay [B]doublet [Higgs particle]new physicsPhysicsHigh Energy Physics - Lattice (hep-lat)ddc:530Electroweak interactionlepton: flavor: violationhep-phParticle Physics - LatticeMonte Carlo [numerical calculations]electron positron: colliding beamsQuarkoniumasymmetry: CPquarkonium physicselectroweak interaction: penguinHigh Energy Physics - PhenomenologyImproved performancecolliding beams [electron positron]CP violationinterfaceelectroproduction [quarkonium]electroweak precision measurementsnumerical calculations: Monte CarlophysicsParticle Physics - ExperimentperformanceParticle physicsflavor: violation [lepton]reviewhep-latFOS: Physical sciencesBELLEHigh Energy Physics - Experiment; High Energy Physics - Experiment; High Energy Physics - Lattice; High Energy Physics - Phenomenologyelectron positron: annihilationquarkonium: electroproductionCP [asymmetry]E(6)Higgs particle: doubletmixing [D0 anti-D0]Theoretical physicsCP: violation: time dependenceHigh Energy Physics - LatticeKEK-B0103 physical sciencesquantum chromodynamicshidden sector [photon]ddc:530composite010306 general physicsColliderParticle Physics - PhenomenologyHigh Energy Physics - Experiment; High Energy Physics - Lattice; High Energy Physics - Phenomenologyphoton: hidden sectorhep-ex010308 nuclear & particles physics[PHYS.HLAT]Physics [physics]/High Energy Physics - Lattice [hep-lat]C50 Other topics in experimental particle physicsviolation: time dependence [CP]D0 anti-D0: mixingB2TiP530 PhysikExperimental physicsB: leptonic decayCKM matrix[PHYS.HPHE]Physics [physics]/High Energy Physics - Phenomenology [hep-ph]penguin [electroweak interaction]leptonic decay [B]semileptonic decay [B]charmparticle identificationexperimental results
researchProduct

Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a…

2020

Background Accurate and up-to-date assessment of demographic metrics is crucial for understanding a wide range of social, economic, and public health issues that affect populations worldwide. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 produced updated and comprehensive demographic assessments of the key indicators of fertility, mortality, migration, and population for 204 countries and territories and selected subnational locations from 1950 to 2019. Methods 8078 country-years of vital registration and sample registration data, 938 surveys, 349 censuses, and 238 other sources were identified and used to estimate age-specific fertility. Spatiotemporal Gaussian…

Malevery elderlyDemographic transitionHALE030204 cardiovascular system & hematologypreschool childGlobal Burden of DiseaseCarga Global de Enfermedades0302 clinical medicinenewbornRisk FactorsSurveys and Questionnairesand Risk Factors Study80 and over030212 general & internal medicineBirth RateChildMigration11 Medical and Health SciencesAged 80 and overeducation.field_of_studyInjuriesGeographyMortality rate1. No povertyDEATHCensusesGeneral MedicineSDG 10 - Reduced InequalitiesMiddle AgedDemographic analysis3142 Public health care science environmental and occupational health3. Good healthdemographic analysisEstilo de Vida SaludableGeographyrisk factorChild Preschool/dk/atira/pure/sustainabledevelopmentgoals/reduced_inequalitiesDemography/statistics & numerical dataGlobal Burden of Diseases Injuries Risk Factors Fertility Mortality Migration Population/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingepidemiologyFemaleA990 Medicine and Dentistry not elsewhere classifiedCHILD-MORTALITYLive BirthGlobal Health MetricsTRANSITIONdemographics ; GBD ; fertility ; mortality ; haleAdultAdolescentTotal fertility ratePopulationPopulation.Global Burden of Diseases Injuries and Risk Factors StudyBirth rate03 medical and health sciencesYoung AdultLife ExpectancySDG 3 - Good Health and Well-beingGeneral & Internal MedicineSYSTEMATIC ANALYSISDemografíaHumansGlobal Burden of Disease StudyhumanMortalityeducationPreschoolAgedDemographySpatial AnalysisquestionnaireInfant NewbornKlinisk medicinHIVInfantGlobal Burden of Diseasessex-specific fertilityMortality rateLive Birth/epidemiology//purl.org/pe-repo/ocde/ford#3.02.00 [https].Global Burden of DiseasesMODELFertilidadFertilityDemographic changeLife expectancyNAglobal disease burdenClinical Medicinepopulation researchDemographyThe Lancet
researchProduct

Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortalit…

2021

Background: Sustainable Development Goal 3.2 has targeted elimination of preventable child mortality, reduction of neonatal death to less than 12 per 1000 livebirths, and reduction of death of children younger than 5 years to less than 25 per 1000 livebirths, for each country by 2030. To understand current rates, recent trends, and potential trajectories of child mortality for the next decade, we present the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 findings for all-cause mortality and cause-specific mortality in children younger than 5 years of age, with multiple scenarios for child mortality in 2030 that include the consideration of potential effects of COVID-…

MalePerinatal careNewborn careSTILLBIRTHSRJ101UNDER-5 MORTALITYPsychological intervention010501 environmental sciencesInfant mortalityGlobal Health01 natural sciences0302 clinical medicineRA0421Cause of DeathInfant MortalityGlobal healthLife TablesHealthcare improvements030212 general & internal medicine610 Medicine &amp; healthChildCause of Death; Child; COVID-19; Global Health; Humans; Infant; Life Tables; SARS-CoV-2; Sustainable Development11 Medical and Health SciencesCause of deathLife TableMortality rate1. No povertyPublic Health Global Health Social Medicine and EpidemiologyGeneral MedicineArticlesHälsovetenskaperSustainable DevelopmentMortality analyses3. Good healthPeer reviewChild PreschoolSDG 1 - No PovertyChild MortalityFemaleLife Sciences & BiomedicineHumanChild mortalityCOUNTRIESDEATHSInfants -- MortalitatGBD610 Medicine & health03 medical and health sciencesMedicine General & InternalSDG 3 - Good Health and Well-beingLife tablesunder-5 mortality rateGeneral & Internal MedicineHealth SciencesNeonatal deathsmedicineSYSTEMATIC ANALYSISHumans:Medicine [Science]Infants -- SalutPreschool0105 earth and related environmental sciencesScience & TechnologyInfants nadons -- Salutbusiness.industrySARS-CoV-2Infants nadons -- MortalitatINFORMInfant NewbornCOVID-19InfantNeonatal and child health ; Sustainable Development Goal 3.2 ; Global healthGBD 2019 Under-5 Mortality Collaboratorsmedicine.diseaseNewbornTRENDSInfant mortalitySustainable Development GoalChild mortalityFolkhälsovetenskap global hälsa socialmedicin och epidemiologiDeaths3121 General medicine internal medicine and other clinical medicineRGbusinessSystematic AnalysisMalariaDemography
researchProduct

SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study

2021

Abstract Background Preoperative SARS-CoV-2 vaccination could support safer elective surgery. Vaccine numbers are limited so this study aimed to inform their prioritization by modelling. Methods The primary outcome was the number needed to vaccinate (NNV) to prevent one COVID-19-related death in 1 year. NNVs were based on postoperative SARS-CoV-2 rates and mortality in an international cohort study (surgical patients), and community SARS-CoV-2 incidence and case fatality data (general population). NNV estimates were stratified by age (18–49, 50–69, 70 or more years) and type of surgery. Best- and worst-case scenarios were used to describe uncertainty. Results NNVs were more favourable in su…

MaleCOVID-19 Vaccinesafe surgery; vaccination modelling; COVID-19Vascular damage Radboud Institute for Health Sciences [Radboudumc 16]MULTICENTERComorbidity030230 surgery0302 clinical medicinephase 3 clinical trial (topic)Case fatality rateProspective StudiesSARS-CoV-2 Vaccination Safe surgeryCOVID-19/epidemiologySARS-CoV-2 ; vaccination ; safe surgeryeducation.field_of_studycase fatality rateVaccinationVaccinationAdolescent; Adult; Aged; COVID-19; COVID-19 Vaccines; Comorbidity; Elective Surgical Procedures; Female; Humans; Male; Middle Aged; Postoperative Complications; Preoperative Period; Prospective Studies; SARS-CoV-2; Vaccination; Young Adulthealth care policyElective Surgical Procedures030220 oncology & carcinogenesisvaccination modellingPreoperative PeriodCOVID-19; SARS-CoV-2; cancer; vaccination; outcome; mortality; infection; modellingCohort studyprospective studyHumanmedicine.medical_specialtyArticle03 medical and health sciencesSARS-CoV-2 vaccinationSDG 3 - Good Health and Well-beingCOVID-19 Vaccines/pharmacologyHumansVaccination/methodsElective surgeryeducationAgedScience & TechnologyElective Surgical Procedureadult; aged; Article; cancer grading; cancer surgery; case fatality rate; computer assisted tomography; elective surgery; female; follow up; health care policy; human; incidence; infection rate; infection risk; major clinical study; male; middle aged; mortality; outcome assessment; phase 3 clinical trial (topic); preoperative care; prospective study; sensitivity analysis; seroprevalence; Severe acute respiratory syndrome coronavirus 2; vaccination; young adult; COVID-19; COVID-19 Vaccines; Comorbidity; Elective Surgical Procedures; Postoperative Complications; Preoperative Period; SARS-CoV-2; Vaccination; surgery.Cura preoperatòriamajor clinical studymortalityinfectionProspective StudieincidenceSurgeryHuman medicinePostoperative Complication610 Medizin und GesundheitAcademicSubjects/MED00910Settore MED/18 - CHIRURGIA GENERALESettore MED/29 - CHIRURGIA MAXILLOFACCIALEcomputer assisted tomographyESTUDOS PROSPECTIVOSsurgerysafe surgeryPostoperative Complicationssensitivity analysisSevere acute respiratory syndrome coronavirus 2preoperative careVacunacióProspective cohort studyseroprevalenceIncidence (epidemiology)covidElective Surgical Procedures/methodsMiddle Agedcancer gradingCOVID vaccinationoutcome/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_beingSARS-CoV-2; vaccination; surgeryOriginal ArticleFemalecancer surgeryAcademicSubjects/MED00010Life Sciences & BiomedicineAdultCOVID-19 VaccinesAdolescentinternational prospective cohort studyPostoperative Complications/prevention & controlPopulationinfection rateSARS-CoV-2/immunologyNOmodellingYoung Adultmedicinefollow upcancerddc:610infection riskoutcome assessmentLS7_4business.industrySARS-CoV-2Number needed to vaccinatePreoperative careCOVID-193126 Surgery anesthesiology intensive care radiologySettore MED/18Reconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10]elective surgeryEmergency medicinebusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyThe British Journal of Surgery
researchProduct

The Large Hadron–Electron Collider at the HL-LHC

2021

The Large Hadron-Electron Collider (LHeC) is designed to move the field of deep inelastic scattering (DIS) to the energy and intensity frontier of particle physics. Exploiting energy-recovery technology, it collides a novel, intense electron beam with a proton or ion beam from the High-Luminosity Large Hadron Collider (HL-LHC). The accelerator and interaction region are designed for concurrent electron-proton and proton-proton operations. This report represents an update to the LHeC's conceptual design report (CDR), published in 2012. It comprises new results on the parton structure of the proton and heavier nuclei, QCD dynamics, and electroweak and top-quark physics. It is shown how the LH…

energy recoverylepton nucleus: scatteringparton: distribution functionhiukkasfysiikka7. Clean energy01 natural sciencesaccelerator physicsHigh Energy Physics - Phenomenology (hep-ph)HEAVY FLAVOR CONTRIBUTIONSenergy-recovery- linacNuclear Experimentcolliding beams [electron p]deep-inelastic scatteringtop and electroweak physicsnew physicsPhysicsSTRUCTURE-FUNCTION RATIOSMonte Carlo [numerical calculations]buildingsprimary [vertex]High Energy Physics - Phenomenologyelectron p: colliding beamskinematicsNuclear Physics - Theoryfinal state: hadronicp: distribution functionbeyond Standard Modelvertex: primarynumerical calculations: Monte Carlodistribution function [parton]High-lumiLHCSTRUCTURE-FUNCTION F-2(X[PHYS.NUCL]Physics [physics]/Nuclear Theory [nucl-th]ion: beam[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex]114 Physical sciencesNuclear Theory (nucl-th)deep inelastic scatteringquantum chromodynamicsddc:530010306 general physicsdeep-inelastic scattering; high-lumi LHC; QCD; Higgs; top and electroweak physics; nuclear physics; beyond standard Model; energy-recovery- linac; accelerator physics010308 nuclear & particles physicshigh-lumi LHCresolutionscattering [electron p]structure function [nucleus]sensitivitybeam [electron]energy-recovery-linacHiggsacceptanceNuclear TheoryHIGH-ENERGY FACTORIZATIONdistribution function [p]density [parton]Higgs; High-lumi LHCHigh Energy Physics - Experimentdesign [detector]High Energy Physics - Experiment (hep-ex)electron: linear acceleratorelectron hadron: scatteringCERN LHC Coll: upgrade[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]scattering [electron hadron]FCCelectron: beamNuclear Experiment (nucl-ex)linear accelerator [electron]Nuclear ExperimentlatticesuperconductivityEnergy-recoverylinacBeyond Standard ModeNuclear physics; QCDelectron nucleus: colliding beamsparton: densitycolliding beams [electron nucleus]Particle Physics - ExperimentNUCLEON STRUCTURE FUNCTIONSNuclear and High Energy Physicsscattering [lepton nucleus]beam [ion]FOS: Physical sciencesnucleus: structure functionhadronic [final state]electron p: scatteringTRANSVERSE-MOMENTUM DEPENDENCEnuclear physics0103 physical sciencesNuclear Physics - Experimentstructureupgrade [CERN LHC Coll]detector: designParticle Physics - PhenomenologyDEEP-INELASTIC-SCATTERINGelectroweak interaction3-LOOP SPLITTING FUNCTIONSCLASSICAL RADIATION ZEROScalibrationAccelerators and Storage RingsQCDmagnethigh [current]13. Climate action[PHYS.HPHE]Physics [physics]/High Energy Physics - Phenomenology [hep-ph]LHeCPhysics::Accelerator PhysicsJET CROSS-SECTIONSHigh Energy Physics::Experimentcurrent: highJournal of Physics G: Nuclear and Particle Physics
researchProduct

Five insights from the Global Burden of Disease Study 2019

2020

The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 provides a rules-based synthesis of the available evidence on levels and trends in health outcomes, a diverse set of risk factors, and health system responses. GBD 2019 covered 204 countries and territories, as well as first administrative level disaggregations for 22 countries, from 1990 to 2019. Because GBD is highly standardised and comprehensive, spanning both fatal and non-fatal outcomes, and uses a mutually exclusive and collectively exhaustive list of hierarchical disease and injury causes, the study provides a powerful basis for detailed and broad insights on global health trends and emerging challenges. GBD …

health care deliveryMaleHumans -- MalatiesOutcome Assessmentglobal healthDiseaseReviewinsights030204 cardiovascular system & hematologySocioeconomic FactorgeographyGlobal Burden of DiseaseNoncommunicable Diseasedisease burdenCarga Global de Enfermedades0302 clinical medicineRisk FactorsOutcome Assessment Health CareHealth careGlobal healthDelivery of health carehealth outcomesmiddle income countrybirth rate030212 general & internal medicineBirth Ratehealth outcomes health system responses economic developmentFactores de Riesgopublic healthhealth care costGeneral MedicineRisk factor (computing)humanities3. Good healthfemalepriority journalrisk factorhealth system responsesepidemiologyTERRITORIESpoliticsCLINICAL-TRIALSmedicine.medical_specialtyBirth Rate; Delivery of Health Care; Global Burden of Disease; Noncommunicable Diseases; Outcome Assessment Health Care; Risk Factors; Socioeconomic Factors; Wounds and Injuries; epidemiologyinjury2019195 COUNTRIESArticleGlobal Burden of Diseases health outcomes risk factors health system responsesHealthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18]03 medical and health sciencessocioeconomicsmedicineSYSTEMATIC ANALYSISHumansGlobal Burden of Disease StudyhumanEpidemiologiaNoncommunicable DiseasesDisease burdenActuarial sciencehigh income countrybusiness.industryRisk FactorWounds and InjuriePublic healthagingHealth careeconomicsNon-communicable diseasemedicine.diseaseSalut públicaeconomic developmentEnfermedadesnon communicable disease//purl.org/pe-repo/ocde/ford#3.02.00 [https]Health CareRisk factorsSocioeconomic Factorspopulation growthLife expectancylife expectancyWounds and InjuriesNAPrestación de Atención de Saludglobal disease burdenbusinessDelivery of Health Carelow income country
researchProduct

Subnational mapping of HIV incidence and mortality among individuals aged 15-49 years in sub-Saharan Africa, 2000-18: a modelling study

2021

Background. High-resolution estimates of HIV burden across space and time provide an important tool for tracking and monitoring the progress of prevention and control efforts and assist with improving the precision and efficiency of targeting efforts. We aimed to assess HIV incidence and HIV mortality for all second-level administrative units across sub-Saharan Africa. Methods. In this modelling study, we developed a framework that used the geographically specific HIV prevalence data collected in seroprevalence surveys and antenatal care clinics to train a model that estimates HIV incidence and mortality among individuals aged 15–49 years. We used a model-based geostatistical framework to e…

0301 basic medicinesub-Saharan AfricaMaleHIV AntibodieEpidemiologyHIV incidencesHIV Infectionsmortality rateHIV AntibodiesModelling studyHuman immunodeficiency virus prevalence0302 clinical medicineAfrica NorthernRA0421Seroepidemiologic StudiesMedicineNorthernHIV Infection030212 general & internal medicineYoung adult10. No inequalityuncertaintyMozambique11 Medical and Health SciencesHIV mortalityMortality rateIncidence (epidemiology)Incidence1. No povertyHiv incidencearticleMauritaniaHuman immunodeficiency virus infected patientArticlestrackingMiddle Agedhealth care planning3. Good healthPeer reviewLesothoAIDSInfectious DiseasesQR180A990 Medicine and Dentistry not elsewhere classifiedFemaleprenatal careanti human immunodeficiency virus agentseroepidemiologyHumanAdultAdolescentAnti-HIV AgentsImmunologyantiretroviral therapyUnit (housing)03 medical and health sciencesYoung AdultbloodHuman immunodeficiency virus infectionVirologySeroprevalenceHumanshumanDeveloping CountriesEstimationAcquired Immunodeficiency SyndromeSubnational mappingsbusiness.industrySeroepidemiologic StudieHIVAnti-HIV AgentPREVENTION030112 virologymortalitymonitoring3121 General medicine internal medicine and other clinical medicineHuman immunodeficiency virus antibodyAfricabusinessHIV incidence ; HIV mortality ; Subnational mapping ; Sub-Saharan Africa ; Local burden of disease ; Public healthDemography
researchProduct

CCDC 174510: Experimental Crystal Structure Determination

2002

Related Article: F.Escarti, C.Miranda, L.Lamarque, J.Latorre, E.Garcia-Espana, M.Kumar, V.J.Aran, P.Navarro|2002|Chem.Commun.||936|doi:10.1039/b110409h

Space GroupCrystallographyCrystal Systembis(mu4-111(35)-Dipyrazola-391319-tetra-azacycloicosaphane)-diaqua-bis(perchlorato-O)-tetra-copper(ii) diperchlorate dihydrateCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct